Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Revenue Recognition (Details Textual)

v3.21.2
Note 2 - Revenue Recognition (Details Textual) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Proceeds from Laboratory Services Reimbursed by Medicare   $ 0.5
Contract with Customer, Liability, Total $ 20.1 $ 20.0
Contract with Customer, Liability, Revenue Recognized $ 9.7